6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0108 770-25-1-801-0136 -National CMOP FENOFIBRATE 48mg
ID: 36C77025Q0108Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/1fac6d42d3594fb7a507e938277c5d6b/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate 48mg tablets for the National CMOP (Consolidated Mail Outpatient Pharmacy) facility. The solicitation, numbered 36C77025Q0108, requires vendors to provide specific quantities of the medication, with strict adherence to the Drug Supply Chain Security Act and the Buy American statute. This procurement is critical for ensuring the timely delivery of essential pharmaceuticals to veterans, with a closing date for submissions set for January 8, 2025, at 9:00 AM CST, and an estimated award date of January 13, 2025. Interested parties should submit their quotes and required documentation, including a signed SF1449 form and state wholesale distributor license, to Michael W. McAlhaney at Michael.McAlhaney@va.gov.

    Point(s) of Contact
    McAlhaney, Michael W.Contract Specialist
    (913) 684-0134
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0108_1.docx
    This document outlines a Request for Proposal (RFP) issued by the Department of Veterans Affairs Network Contracting Office 15 for pharmaceutical supplies. The solicitation is geared towards acquiring various medications, specifically fenofibrate tablets, to fulfill the healthcare needs of veterans. The order includes detailed requirements for delivery, compliance, and submission expectations, emphasizing the necessity for vendors to provide quantity confirmations, product origin, and adherence to Drug Supply Chain Security Act provisions. Key points include the requirement for barcoding on pharmaceutical products, adherence to therapeutic equivalence standards, and protocols concerning recalls. Vendors must submit multiple documents, including a signed SF 1449 form, a price schedule, and specific regulatory compliance certificates to ascertain eligibility. The schedule outlines delivery destinations across multiple locations with stringent timelines. Payment terms are defined, alongside guidelines for invoicing and reporting, ensuring transparency and compliance with federal regulations. This RFP serves to procure critical pharmaceuticals while ensuring the process aligns with government procurement standards and small business participation criteria, illustrating the government's commitment to providing quality health services to veterans through systematic and regulated procurement methods.
    36C77025Q0108.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for an emergency procurement of FENOFIBRATE 48mg pharmaceuticals, designated under solicitation number 36C77025Q0108. The contract, set aside for small businesses, entails delivery to multiple VA locations within ten days after receipt of order. Proposals are due by January 8, 2025, with an estimated award date of January 13, 2025. Vendors must submit comprehensive quotes, including an Excel price schedule, proof of state licensing in compliance with the Drug Supply Chain Security Act, and documentation related to the Buy American Act for foreign products. All submissions should be directed to the designated contracting officer, Michael W. McAlhaney, via email. The notice emphasizes that all quotations must accurately address the specified requirements, ensuring an orderly procurement process while highlighting the VA's commitment to meeting its pharmaceutical needs.
    52.225-2 BUY AMERICAN CERTIFICATE.docx
    The document outlines the Buy American Certificate requirements for Offerors in U.S. government procurement. It certifies that each end product is a domestic end product, except for those noted in provided sections. Offerors must identify foreign end products manufactured in the U.S. that do not qualify and indicate their domestic content percentages, unless designated as commercially available off-the-shelf (COTS) items. Specific definitions for terms like "critical component" and "foreign end product" are stipulated. Offerors are required to furnish line item numbers for domestic products containing critical components and document relevant foreign end products, including country of origin and domestic content status. Offers will be evaluated in accordance with the regulations in part 25 of the Federal Acquisition Regulation. This provision emphasizes the government’s commitment to supporting domestic manufacturing and ensuring compliance with established procurement policies.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0108.xlsx
    The document outlines a Request for Quote (RFQ) issued by the VA for the procurement of Fenofibrate 48MG tablets. The RFQ number is 36C77025Q0108, with an anticipated issue date of December 31, 2024, and it specifies a closing date of January 8, 2025, at 9:00 AM CST. Award announcements are expected on January 13, 2025, with estimated delivery set for January 28, 2025, following a 10-day period after receipt of order (ARO). The solicitation details the quantities and packaging requirements for the product, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA). Vendors must provide necessary documentation, including state wholesale distributor licensure, to demonstrate compliance, or they risk being deemed technically unacceptable. Required submission documents include a signed SF1449 solicitation cover page, price quotes in Excel format, state licenses, and a completed Buy American Certificate. Contact information for procurement officials is provided, indicating the various distribution centers involved, alongside shipping locations for order delivery. This RFQ underscores the commitment to regulatory adherence while facilitating procurement processes for essential pharmaceutical products.
    Similar Opportunities
    6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Fexofenadine HCL 60MG (500CT) for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). Vendors are required to submit detailed quotes that include a signed SF1449 solicitation cover page, a completed pricing schedule, a valid wholesale distributor license, and OEM authorization for over-the-counter products, ensuring compliance with the Buy American Act and other regulatory standards. This pharmaceutical product is critical for treating allergies and must meet stringent quality and safety requirements, including a minimum shelf life of one year upon delivery. Proposals are due by January 10, 2025, at 3:00 PM CT, and interested vendors can contact Contract Specialist Jennifer D Coleman at jennifer.coleman4@va.gov for further information.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--761-25-1-015-0001 -Chelmsford CMOP Pharm -(VA-25-00012051)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for various pharmaceutical products to be supplied to the Chelmsford VA Center facility. The procurement includes items such as a vaginal gel, multivitamin tablets, and a wound therapy solution, with specific quantities and packaging requirements outlined for each product. This solicitation underscores the VA's commitment to ensuring a stable supply of essential medications for veterans while adhering to federal procurement regulations. Interested vendors must submit their quotations by January 17, 2025, and provide necessary documentation, including a state wholesale distributor license and OEM authorization, to the designated contract specialist, Lacie Nowak, at Lacie.nowak@va.gov.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--765-25-1-021-0009 -Hines CMOP ACAMPROSATE -(VA-25-00012693)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Acamprosate Calcium 333mg, specifically for the Hines Consolidated Mail Outpatient Pharmacy (CMOP). This solicitation, identified by requisition number 36C77025Q0022, requires vendors to comply with federal regulations, including adherence to the Buy American Act, and mandates that all products have a minimum expiration date of one year upon delivery. The procurement is critical for ensuring reliable access to essential pharmaceuticals for veterans, emphasizing quality assurance and regulatory compliance throughout the process. Interested vendors must submit their quotes by January 10, 2025, at 3:00 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov or by phone at 913-758-9934.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    6505--Metformin IR Tablets - REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL IR Tablets under solicitation number 36E79725R0013. This procurement aims to ensure a consistent supply of Metformin for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with a contract term of one year and four optional annual extensions. The successful bidders must provide unique drug labeling with a distinct National Drug Code (NDC), as the packaging must exclusively display the contractor's label without overlapping with others. The solicitation is expected to be released electronically on January 21, 2025, with a submission deadline of February 4, 2025. Interested parties can direct inquiries to Contracting Officer Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.